A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy
Public ClinicalTrials.gov record NCT07412496. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Vehicle-Controlled, Double-Masked, Parallel-Group Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter, double-masked study to evaluate the use of Topical Ocular BL1332 for the management of post-operative pain after Photorefractive Keratectomy (PRK) surgery.
Study identification
- NCT ID
- NCT07412496
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 130 participants
Conditions and interventions
Conditions
Interventions
- Topical Ocular BL1332 low dose Drug
- Topical Ocular BL1332 high dose Drug
- BL1332 Vehicle ophthalmic vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 58 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2026 (Actual)
- Primary completion
- Oct 4, 2026 (Actual)
- Completion
- Oct 4, 2026 (Actual)
- Last update posted
- Oct 22, 2026
2026
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 14 | Scottsdale | Arizona | 85250 | — |
| Site 3 | Long Beach | California | 90805 | — |
| Site 10 | Pasadena | California | 91107 | — |
| Site 11 | San Diego | California | 92122 | — |
| Site 15 | Davie | Florida | 33324 | — |
| Site 13 | Brookline | Massachusetts | 02445 | — |
| Site 5 | Bloomington | Minnesota | 55420 | — |
| Site 8 | Amherst | New York | 14228 | — |
| Site 9 | Fargo | North Dakota | 58103 | — |
| Site 6 | West Fargo | North Dakota | 58078 | — |
| Site 1 | Sioux Falls | South Dakota | 57108 | — |
| Site 2 | Cedar Park | Texas | 78613 | — |
| Site 12 | Draper | Utah | 84020 | — |
| Site 4 | Salt Lake City | Utah | 84107 | — |
| Site 7 | Lynchburg | Virginia | 24502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07412496, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 22, 2026 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07412496 live on ClinicalTrials.gov.